Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kitchen, PRB; Smith, HJ; Henderson, MA; Goldhirsch, A; Castiglione-Gertsch, M; Coates, AS; Gusterson, B; Brown, RW; Gelber, RD; Collins, JP
   Tubular carcinoma of the breast: Prognosis and response to adjuvant systemic therapy
   ANZ journal of surgery
   
   P.R.B. Kitchen et al., "Tubular carcinoma of the breast: Prognosis and response to adjuvant systemic therapy", AUST NZ J S, 71(1), 2001, pp. 27-31
2. Colleoni, M; Gelber, RD; Gelber, S; Castiglione-Gertsch, M; Coates, AS; Goldhirsch, A
   How to improve timing and duration of adjuvant chemotherapy
   BREAST
   
   M. Colleoni et al., "How to improve timing and duration of adjuvant chemotherapy", BREAST, 10, 2001, pp. 101-105
3. Thurlimann, B; Price, KN; Castiglione, M; Coates, AS; Goldhirsch, A; Gelber, RD; Forbes, J; Holmberg, S; Veronesi, A; Bernhard, J; Zahrieh, D
   Randomized controlled trial of ovarian function suppression plus tamoxifenversus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11-93
   BREAST
   
   B. Thurlimann et al., "Randomized controlled trial of ovarian function suppression plus tamoxifenversus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11-93", BREAST, 10, 2001, pp. 130-138
4. Bonetti, M; Gelber, RD; Goldhirsch, A; Castiglione-Gertsch, M; Coates, AS
   Features that predict responsiveness to chemotherapy and endocrine therapies
   BREAST
   
   M. Bonetti et al., "Features that predict responsiveness to chemotherapy and endocrine therapies", BREAST, 10, 2001, pp. 147-157
5. Coates, AS; Hurny, C; Peterson, HF; Bernhard, J; Castiglione-Gertsch, M; Gelber, RD; Goldhirsch, A
   Quality of life scores predict outcome in metastatic but not in early breast cancer
   BREAST
   
   A.S. Coates et al., "Quality of life scores predict outcome in metastatic but not in early breast cancer", BREAST, 10, 2001, pp. 164-170
6. Curigliano, G; Ferretti, G; Colleoni, M; Marrocco, E; Peruzzotti, G; De Cicco, C; Paganelli, G; Goldhirsch, A
   Bone scan had no role in the staging of 765 consecutive operable T1-2N0-1 breast cancer patients without skeletal symptoms
   ANNALS OF ONCOLOGY
   
   G. Curigliano et al., "Bone scan had no role in the staging of 765 consecutive operable T1-2N0-1 breast cancer patients without skeletal symptoms", ANN ONCOL, 12(5), 2001, pp. 724-725
7. Crivellari, D; Pagani, O; Veronesi, A; Lombardi, D; Nole, F; Thurlimann, B; Hess, D; Borner, M; Bauer, J; Martinelli, G; Graffeo, R; Sessa, C; Goldhirsch, A
   High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel
   ANNALS OF ONCOLOGY
   
   D. Crivellari et al., "High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel", ANN ONCOL, 12(3), 2001, pp. 353-356
8. Nole, F; Munzone, E; Mandala, M; Catania, C; Orlando, L; Zampino, MG; Minchella, I; Colleoni, M; Peruzzotti, G; Marrocco, E; Goldhirsch, A
   Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: A phase II study
   ANNALS OF ONCOLOGY
   
   F. Nole et al., "Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: A phase II study", ANN ONCOL, 12(1), 2001, pp. 95-100
9. Gelber, S; Coates, AS; Goldhirsch, A; Castiglione-Gertsch, M; Marini, G; Lindtner, J; Edelmann, DZ; Gudgeon, A; Harvey, V; Gelber, RD
   Effect of pregnancy on overall survival after the diagnosis of early-stagebreast cancer
   JOURNAL OF CLINICAL ONCOLOGY
   
   S. Gelber et al., "Effect of pregnancy on overall survival after the diagnosis of early-stagebreast cancer", J CL ONCOL, 19(6), 2001, pp. 1671-1675
10. Colleoni, M; Gelber, S; Coates, AS; Castiglione-Gertsch, M; Gelber, RD; Price, K; Rudenstam, CM; Lindtner, J; Collins, J; Thurlimann, B; Holmberg, SB; Cortes-Funes, H; Simoncini, E; Murray, E; Fey, M; Goldhirsch, A
    Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    M. Colleoni et al., "Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer", J CL ONCOL, 19(21), 2001, pp. 4141-4149
11. Goldhirsch, A; Glick, JH; Gelber, RD; Coates, AS; Senn, HJ
    Meeting highlights: International consensus panel on the treatment of primary breast cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    A. Goldhirsch et al., "Meeting highlights: International consensus panel on the treatment of primary breast cancer", J CL ONCOL, 19(18), 2001, pp. 3817-3827
12. Colleoni, M; Goldhirsch, A; Coates, A; Gelber, R; Castiglione-Gertsch, M
    Bone metastases in breast cancer: How to prevent? In reply
    JOURNAL OF CLINICAL ONCOLOGY
    
    M. Colleoni et al., "Bone metastases in breast cancer: How to prevent? In reply", J CL ONCOL, 19(10), 2001, pp. 2764-2765
13. Curigliano, G; Ferretti, G; Flamini, G; Goldhirsch, A; de Braud, F; Calabro, MG; Mandaly, M; Nole, F; De Pas, T; D'Addessi, A; Cittadini, A
    Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradientgel electrophoresis urinalysis
    ANTICANCER RESEARCH
    
    G. Curigliano et al., "Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradientgel electrophoresis urinalysis", ANTICANC R, 21(4B), 2001, pp. 3015-3020
14. De Pas, T; de Braud, F; Mandala, M; Curigliano, G; Catania, C; Ferretti, G; Sozzi, P; Solli, P; Goldhirsch, A
    Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine
    LUNG CANCER
    
    T. De Pas et al., "Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine", LUNG CANC, 31(2-3), 2001, pp. 267-270
15. Cole, BF; Gelber, RD; Gelber, S; Coates, AS; Goldhirsch, A
    Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis
    LANCET
    
    B.F. Cole et al., "Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis", LANCET, 358(9278), 2001, pp. 277-286
16. Biffi, R; De Braud, F; Orsi, F; Pozzi, S; Arnaldi, P; Goldhirsch, A; Rotmensz, N; Robertson, C; Bellomi, M; Andreoni, B
    A randomized, prospective trial of central venous ports connected to standard open-ended or groshong catheters in adult oncology patients
    CANCER
    
    R. Biffi et al., "A randomized, prospective trial of central venous ports connected to standard open-ended or groshong catheters in adult oncology patients", CANCER, 92(5), 2001, pp. 1204-1212
17. Mancuso, P; Burlini, A; Pruneri, G; Goldhirsch, A; Martinelli, G; Bertolini, F
    Resting and activated endothelial cells are increased in the peripheral blood of cancer patients
    BLOOD
    
    P. Mancuso et al., "Resting and activated endothelial cells are increased in the peripheral blood of cancer patients", BLOOD, 97(11), 2001, pp. 3658-3661
18. Ferretti, G; Curigliano, G; Pastorino, U; Cittadini, A; Flamini, G; Calabro, MG; De Pas, T; Orlando, L; Mandala, M; Colleoni, M; Spaggiari, L; Granone, PL; Pagliari, G; de Braud, F; Fazio, N; Goldhirsch, A
    Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer
    CLINICAL CANCER RESEARCH
    
    G. Ferretti et al., "Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer", CLIN CANC R, 6(6), 2000, pp. 2393-2400
19. Colleoni, M; Orlando, L; Nole, F; Goldhirsch, A
    Introducing taxanes in the adjuvant treatment of breast cancer: expectations and reality
    BREAST
    
    M. Colleoni et al., "Introducing taxanes in the adjuvant treatment of breast cancer: expectations and reality", BREAST, 9(3), 2000, pp. 134-138
20. Castiglione-Gertsch, M; Gelber, RD; O'Neill, A; Coates, AS; Goldhirsch, A
    Systemic adjuvant treatment for premenopausal node-negative breast cancer
    EUROPEAN JOURNAL OF CANCER
    
    M. Castiglione-Gertsch et al., "Systemic adjuvant treatment for premenopausal node-negative breast cancer", EUR J CANC, 36(4), 2000, pp. 549-550
21. Piccart, M; Goldhirsch, A; Straehle, C
    The Breast International Group: a new spirit of collaboration in breast cancer research for the new millennium
    EUROPEAN JOURNAL OF CANCER
    
    M. Piccart et al., "The Breast International Group: a new spirit of collaboration in breast cancer research for the new millennium", EUR J CANC, 36(14), 2000, pp. 1733-1736
22. Pagani, O; Sessa, C; Nole, F; Crivellari, D; Lombardi, D; Thurlimann, B; Hess, D; Borner, M; Bauer, J; Martinelli, G; Graffeo, R; Zucchetti, M; D'Incalci, M; Goldhirsch, A
    Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I-II study
    ANNALS OF ONCOLOGY
    
    O. Pagani et al., "Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I-II study", ANN ONCOL, 11(8), 2000, pp. 985-991
23. Colleoni, M; Minchella, I; Mazzarol, G; Nole, F; Peruzzotti, G; Rocca, A; Viale, G; Orlando, L; Ferretti, G; Curigliano, G; Veronesi, P; Intra, M; Goldhirsch, A
    Response to primary chemotherapy in breast cancer patients with tumors notexpressing estrogen and progesterone receptors
    ANNALS OF ONCOLOGY
    
    M. Colleoni et al., "Response to primary chemotherapy in breast cancer patients with tumors notexpressing estrogen and progesterone receptors", ANN ONCOL, 11(8), 2000, pp. 1057-1059
24. De Pas, T; de Braud, F; Danesi, R; Sessa, C; Catania, C; Curigliano, G; Fogli, S; del Tacca, M; Zampino, G; Sbanotto, A; Rocca, A; Cinieri, S; Marrocco, E; Milani, A; Goldhirsch, A
    Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer
    ANNALS OF ONCOLOGY
    
    T. De Pas et al., "Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer", ANN ONCOL, 11(7), 2000, pp. 821-827
25. Roth, AD; Maibach, R; Martinelli, G; Fazio, N; Aapro, MS; Pagani, O; Morant, R; Borner, MM; Herrmann, R; Honegger, H; Cavalli, F; Alberto, P; Castiglione, M; Goldhirsch, A
    Docetaxel (Taxotere (R))-cisplatin (TC): An effective drug combination in gastric carcinoma
    ANNALS OF ONCOLOGY
    
    A.D. Roth et al., "Docetaxel (Taxotere (R))-cisplatin (TC): An effective drug combination in gastric carcinoma", ANN ONCOL, 11(3), 2000, pp. 301-306
26. Graffeo, R; Pagani, O; Crivelli, M; Zappa, F; Borella, P; Reiner, M; Goldhirsch, A
    Parathyroid hormone-related protein in metastatic breast cancer induced hypercalcemia: A case report
    ANNALS OF ONCOLOGY
    
    R. Graffeo et al., "Parathyroid hormone-related protein in metastatic breast cancer induced hypercalcemia: A case report", ANN ONCOL, 11(1), 2000, pp. 97-100
27. Orlando, L; Colleoni, M; Nole, F; Biffi, R; Rocca, A; Curigliano, G; Ferretti, G; Peruzzotti, G; de Braud, F; Masci, G; Goldhirsch, A
    Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?
    ANNALS OF ONCOLOGY
    
    L. Orlando et al., "Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?", ANN ONCOL, 11(1), 2000, pp. 117-118
28. Crivellari, D; Bonetti, M; Castiglione-Gertsch, M; Gelber, RD; Rudenstam, CM; Thurlimann, B; Price, KN; Coates, AS; Hurny, C; Bernhard, J; Lindtner, J; Collins, J; Senn, HJ; Cavalli, F; Forbes, J; Gudgeon, A; Simoncini, E; Cortes-Funes, H; Veronesi, A; Fey, M; Goldhirsch, A
    Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII
    JOURNAL OF CLINICAL ONCOLOGY
    
    D. Crivellari et al., "Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII", J CL ONCOL, 18(7), 2000, pp. 1412-1422
29. Colleoni, M; Bonetti, M; Coates, AS; Castiglione-Gertsch, M; Gelber, RD; Price, K; Rudenstam, CM; Lindtner, J; Collins, J; Thurlimann, B; Holmberg, S; Veronesi, A; Marini, G; Goldhirsch, A
    Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors
    JOURNAL OF CLINICAL ONCOLOGY
    
    M. Colleoni et al., "Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors", J CL ONCOL, 18(3), 2000, pp. 584-590
30. Colleoni, M; O'Neill, A; Goldhirsch, A; Gelber, RD; Bonetti, M; Thurlimann, B; Price, KN; Castiglione-Gertsch, M; Coates, AS; Lindtner, J; Collins, J; Senn, HJ; Cavalli, F; Forbes, J; Gudgeon, A; Simoncini, E; Cortes-Funes, H; Veronesi, A; Fey, M; Rudenstam, CM
    Identifying breast cancer patients at high risk for bone metastases
    JOURNAL OF CLINICAL ONCOLOGY
    
    M. Colleoni et al., "Identifying breast cancer patients at high risk for bone metastases", J CL ONCOL, 18(23), 2000, pp. 3925-3935
31. Coates, AS; Hurny, C; Peterson, HF; Bernhard, J; Castiglione-Gertsch, M; Gelber, RD; Goldhirsch, A
    Quality-of-life scores predict outcome in metastatic but not early breast cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    A.S. Coates et al., "Quality-of-life scores predict outcome in metastatic but not early breast cancer", J CL ONCOL, 18(22), 2000, pp. 3768-3774
32. Sabbioni, MEE; Siegrist, HP; Bacchi, M; Bernhard, J; Castiglione, M; Thurlimann, B; Bonnefoi, H; Perey, L; Herrmann, R; Goldhirsch, A; Hurny, C
    Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment
    BREAST CANCER RESEARCH AND TREATMENT
    
    M.E.E. Sabbioni et al., "Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment", BREAST CANC, 59(3), 2000, pp. 279-287
33. Colleoni, M; Mandala, M; Peruzzotti, G; Robertson, C; Bredart, A; Goldhirsch, A
    Depression and degree of acceptance of adjuvant cytotoxic drugs
    LANCET
    
    M. Colleoni et al., "Depression and degree of acceptance of adjuvant cytotoxic drugs", LANCET, 356(9238), 2000, pp. 1326-1327
34. Aebi, S; Gelber, S; Castiglione-Gertsch, M; Coates, AS; Goldhirsch, A
    False negatives in oestrogen-receptor assay - Reply
    LANCET
    
    S. Aebi et al., "False negatives in oestrogen-receptor assay - Reply", LANCET, 356(9233), 2000, pp. 944-945
35. Goldhirsch, A; Francis, P; Castiglione-Gertsch, M; Gelber, RD; Coates, AS
    Taxanes as adjuvant for breast cancer
    LANCET
    
    A. Goldhirsch et al., "Taxanes as adjuvant for breast cancer", LANCET, 356(9228), 2000, pp. 507-508
36. Aebi, S; Gelber, S; Castiglione-Gertsch, M; Gelber, RD; Collins, J; Thurlimann, B; Rudenstam, CM; Lindtner, J; Crivellari, D; Cortes-Funes, H; Simoncini, E; Werner, ID; Coates, AS; Goldhirsch, A
    Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
    LANCET
    
    S. Aebi et al., "Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?", LANCET, 355(9218), 2000, pp. 1869-1874
37. Bertolini, F; Paolucci, M; Peccatori, F; Cinieri, S; Agazzi, A; Ferrucci, PF; Cocorocchio, E; Goldhirsch, A; Martinelli, G
    Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma - Reply
    BRITISH JOURNAL OF HAEMATOLOGY
    
    F. Bertolini et al., "Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma - Reply", BR J HAEM, 108(3), 2000, pp. 662-663
38. Munzone, E; Nole, F; Orlando, L; Mandala, M; Biffi, R; Ciano, C; Villa, G; Civelli, M; Goldhirsch, A
    Unexpected right phrenic nerve injury during 5-fluorouracil continuous infusion plus cisplatin and vinorelbine in breast cancer patients
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    E. Munzone et al., "Unexpected right phrenic nerve injury during 5-fluorouracil continuous infusion plus cisplatin and vinorelbine in breast cancer patients", J NAT CANC, 92(9), 2000, pp. 755-755
39. Bernhard, J; Castiglione-Gertsch, M; Schmitz, SFH; Thurlimann, B; Cavalli, F; Morant, R; Fey, MF; Bonnefoi, H; Goldhirsch, A; Hurny, C
    Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: Formestane versus megestrol acetate as second-line hormonaltreatment
    EUROPEAN JOURNAL OF CANCER
    
    J. Bernhard et al., "Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: Formestane versus megestrol acetate as second-line hormonaltreatment", EUR J CANC, 35(6), 1999, pp. 913-920
40. Colleoni, M; Orvieto, E; Nole, F; Orlando, L; Minchella, I; Viale, G; Peruzzotti, G; Robertson, C; Noberasco, C; Galimberti, V; Sacchini, V; Veronesi, P; Zurrida, S; Orecchia, R; Goldhirsch, A
    Prediction of response to primary chemotherapy for operable breast cancer
    EUROPEAN JOURNAL OF CANCER
    
    M. Colleoni et al., "Prediction of response to primary chemotherapy for operable breast cancer", EUR J CANC, 35(4), 1999, pp. 574-579
41. Goldhirsch, A
    Postoperative radiotherapy 'improves survival' in postmenopausal breast cancer - Comment
    EUROPEAN JOURNAL OF CANCER
    
    A. Goldhirsch, "Postoperative radiotherapy 'improves survival' in postmenopausal breast cancer - Comment", EUR J CANC, 35(10), 1999, pp. 1413-1414
42. Sabbioni, MEE; Castiglione, M; Hurny, C; Siegrist, HP; Bacchi, M; Bernhard, J; Thurlimann, B; Bonnefoi, H; Perey, L; Goldhirsch, A; Senn, HJ
    Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients
    SUPPORTIVE CARE IN CANCER
    
    M.E.E. Sabbioni et al., "Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients", SUPP CARE C, 7(3), 1999, pp. 149-153
43. Nole, F; Minchella, I; Colleoni, M; Orvieto, E; Munzone, E; de Braud, F; Peruzzotti, G; Martinelli, G; Zampino, MG; Catania, C; Pizzamiglio, M; Veronesi, P; Zurrida, S; Galimberti, V; Goldhirsch, A; Veronesi, U
    Primary chemotherapy in operable breast cancer with favorable prognostic factors: A pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)
    ANNALS OF ONCOLOGY
    
    F. Nole et al., "Primary chemotherapy in operable breast cancer with favorable prognostic factors: A pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)", ANN ONCOL, 10(8), 1999, pp. 993-996
44. Pagani, O; Sessa, C; Martinelli, G; Crivellari, D; Buonadonna, A; Thurlimann, B; Hess, D; Borner, M; Bauer, J; Zampino, G; Zimatore, M; Graffeo, R; Riva, A; Goldhirsch, A
    Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer
    ANNALS OF ONCOLOGY
    
    O. Pagani et al., "Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer", ANN ONCOL, 10(5), 1999, pp. 539-545
45. Colombo, T; Parisi, I; Zucchetti, M; Sessa, C; Goldhirsch, A; D'Incalci, M
    Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicin
    ANNALS OF ONCOLOGY
    
    T. Colombo et al., "Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicin", ANN ONCOL, 10(4), 1999, pp. 391-395
46. De Pas, T; Martinelli, G; De Braud, F; Peccatori, F; Catania, C; Aapro, MS; Goldhirsch, A
    Friedreich's ataxia and intrathecal chemotherapy in a patient with lymphoblastic lymphoma
    ANNALS OF ONCOLOGY
    
    T. De Pas et al., "Friedreich's ataxia and intrathecal chemotherapy in a patient with lymphoblastic lymphoma", ANN ONCOL, 10(11), 1999, pp. 1393-1393
47. Locatelli, M; Colleoni, M; Noberasco, C; Nole, F; Orlando, L; Munzone, E; Peruzzotti, G; Goldhirsch, A
    Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (cmf regimen)
    ANNALS OF ONCOLOGY
    
    M. Locatelli et al., "Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (cmf regimen)", ANN ONCOL, 10(11), 1999, pp. 1394-1395
48. Bernhard, J; Thurlimann, B; Schmitz, SFH; Castiglione-Gertsch, M; Cavalli, F; Morant, R; Fey, MF; Bonnefoi, H; Goldhirsch, A; Hurny, C
    Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: Does quality of life matter?
    JOURNAL OF CLINICAL ONCOLOGY
    
    J. Bernhard et al., "Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: Does quality of life matter?", J CL ONCOL, 17(6), 1999, pp. 1672-1679
49. Cote, RJ; Peterson, HF; Chaiwun, B; Gelber, RD; Goldhirsch, A; Castiglione-Gertsch, M; Gusterson, B; Neville, AM
    Role of immunohistochemical detection of lymph-node metastases in management of breast cancer
    LANCET
    
    R.J. Cote et al., "Role of immunohistochemical detection of lymph-node metastases in management of breast cancer", LANCET, 354(9182), 1999, pp. 896-900
50. Colleoni, M; Price, KN; Castiglione-Gertsch, M; Gelber, RD; Coates, AS; Goldhirsch, A
    Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil
    LANCET
    
    M. Colleoni et al., "Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil", LANCET, 354(9173), 1999, pp. 130-131
51. Bredart, A; Didier, F; Robertson, C; Scaffidi, E; Fonzo, D; Costa, A; Goldhirsch, A; Autier, P
    Psychological distress in cancer patients attending the European Instituteof Oncology in Milan
    ONCOLOGY
    
    A. Bredart et al., "Psychological distress in cancer patients attending the European Instituteof Oncology in Milan", ONCOL-BASEL, 57(4), 1999, pp. 297-302
52. Bertolini, F; Paolucci, M; Peccatori, F; Cinieri, S; Agazzi, A; Ferrucci, PF; Cocorocchio, E; Goldhirsch, A; Martinelli, G
    Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma
    BRITISH JOURNAL OF HAEMATOLOGY
    
    F. Bertolini et al., "Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma", BR J HAEM, 106(2), 1999, pp. 504-509
53. PAGANI O; ONEILL A; CASTIGLIONE M; GELBER RD; GOLDHIRSCH A; RUDENSTAM CM; LINDTNER J; COLLINS J; CRIVELLARI D; COATES A; CAVALLI F; THURLIMANN B; SIMONCINI E; FEY M; PRICE K; SENN HJ
    PROGNOSTIC IMPACT OF AMENORRHEA AFTER ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER PATIENTS WITH AXILLARY NODE INVOLVEMENT - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI
    European journal of cancer
    
    O. Pagani et al., "PROGNOSTIC IMPACT OF AMENORRHEA AFTER ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER PATIENTS WITH AXILLARY NODE INVOLVEMENT - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI", European journal of cancer, 34(5), 1998, pp. 632-640
54. COLLEONI M; NOLE F; MINCHELLA I; NOBERASCO C; LUINI A; ORECCHIA A; VERONESI P; ZURRIDA S; VIALE G; GOLDHIRSCH A
    PREOPERATIVE CHEMOTHERAPY AND RADIOTHERAPY IN BREAST-CANCER
    European journal of cancer
    
    M. Colleoni et al., "PREOPERATIVE CHEMOTHERAPY AND RADIOTHERAPY IN BREAST-CANCER", European journal of cancer, 34(5), 1998, pp. 641-645
55. COLLEONI M; PRICE K; CASTIGLIONEGERTSCH M; GOLDHIRSCH A; COATES A; LINDTNER J; COLLINS J; GELBER RD; THURLIMANN B; RUDENSTAM CM
    DOSE-RESPONSE EFFECT OF ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN NODE-POSITIVE BREAST-CANCER
    European journal of cancer
    
    M. Colleoni et al., "DOSE-RESPONSE EFFECT OF ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN NODE-POSITIVE BREAST-CANCER", European journal of cancer, 34(11), 1998, pp. 1693-1700
56. GOLDHIRSCH A
    ADJUVANT SYSTEMIC TREATMENT FOR OPERABLE BREAST-CANCER STANDARD THERAPIES AND NEW APPROACHES
    European journal of cancer
    
    A. Goldhirsch, "ADJUVANT SYSTEMIC TREATMENT FOR OPERABLE BREAST-CANCER STANDARD THERAPIES AND NEW APPROACHES", European journal of cancer, 34, 1998, pp. 399-399
57. PINDER SE; MURRAY S; ELLIS IO; TRIHIA H; ELSTON CW; GELBER RD; GOLDHIRSCH A; LINDTNER J; CORTESFUNES H; SIMONCINI E; BYRNE MJ; GOLOUH R; RUDENSTAM CM; CASTIGLIONEGERTSCH M
    THE PREDICTION OF RESPONSE TO CHEMOTHERAPY IN INVASIVE BREAST-CARCINOMA BY DETERMINATION OF HISTOLOGICAL GRADE
    European journal of cancer
    
    S.E. Pinder et al., "THE PREDICTION OF RESPONSE TO CHEMOTHERAPY IN INVASIVE BREAST-CARCINOMA BY DETERMINATION OF HISTOLOGICAL GRADE", European journal of cancer, 34, 1998, pp. 513-513
58. COLLEONI M; MINCHELLA I; ORVIETO E; PERUZZOTTI G; NOLE F; VIALE G; NOBERASCO C; SACCHINI V; VERONESI P; ORECCHIA R; GOLDHIRSCH A
    PREDICTION OF RESPONSE TO PRIMARY CHEMOTHERAPY (PCT) FOR OPERABLE BREAST-CANCER
    European journal of cancer
    
    M. Colleoni et al., "PREDICTION OF RESPONSE TO PRIMARY CHEMOTHERAPY (PCT) FOR OPERABLE BREAST-CANCER", European journal of cancer, 34, 1998, pp. 12-12
59. NOLE F; MUNZONE E; ZAMPINO MG; MINCHELLA I; COLLEONI M; NOBERASCO C; DEPAS T; FAZIO N; DEBRAUD F; PERUZZOTTI G; GOLDHIRSCH A
    CONTINUOUS-INFUSION OF 5-FLUOROURACIL (CIFU) GIVEN WITH VINORELBINE (VI) AND CISPLATIN (P) (VIFUP) IN HEAVILY PRETREATED METASTATIC BREAST-CANCER
    European journal of cancer
    
    F. Nole et al., "CONTINUOUS-INFUSION OF 5-FLUOROURACIL (CIFU) GIVEN WITH VINORELBINE (VI) AND CISPLATIN (P) (VIFUP) IN HEAVILY PRETREATED METASTATIC BREAST-CANCER", European journal of cancer, 34, 1998, pp. 33-33
60. PAGANI O; SESSA C; MARTINELLI G; CRIVELLARI D; GOLDHIRSCH A
    DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (D) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC)
    European journal of cancer
    
    O. Pagani et al., "DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (D) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC)", European journal of cancer, 34, 1998, pp. 37-37
61. GELBER RD; GELBER S; BONETTI M; GOLDHIRSCH A
    QUALITY-OF-LIFE ASSESSMENT IN THE ADJUVANT SETTING - IS IT RELEVANT
    European journal of cancer
    
    R.D. Gelber et al., "QUALITY-OF-LIFE ASSESSMENT IN THE ADJUVANT SETTING - IS IT RELEVANT", European journal of cancer, 34, 1998, pp. 37-37
62. PICCART MJ; BIGANZOLI L; GOLDHIRSCH A
    EORTC AND BIG TRIALS
    European journal of cancer
    
    M.J. Piccart et al., "EORTC AND BIG TRIALS", European journal of cancer, 34, 1998, pp. 43-43
63. JUNGI WF; BERNHARD J; HURNY C; SCHMITZ SFH; HANSELMANN S; GUSSET H; PESTALOZZI D; GOLDHIRSCH A
    EFFECT OF CARBOPLATIN ON RESPONSE AND PALLIATION IN HORMONE-REFRACTORY PROSTATE-CANCER
    Supportive care in cancer
    
    W.F. Jungi et al., "EFFECT OF CARBOPLATIN ON RESPONSE AND PALLIATION IN HORMONE-REFRACTORY PROSTATE-CANCER", Supportive care in cancer, 6(5), 1998, pp. 462-468
64. GOLDHIRSCH A; COATES AS; CASTIGLIONEGERTSCH M; GELBER RD
    NEW TREATMENTS FOR BREAST-CANCER - BREAKTHROUGHS FOR PATIENT-CARE OR JUST STEPS IN THE RIGHT DIRECTION
    Annals of oncology
    
    A. Goldhirsch et al., "NEW TREATMENTS FOR BREAST-CANCER - BREAKTHROUGHS FOR PATIENT-CARE OR JUST STEPS IN THE RIGHT DIRECTION", Annals of oncology, 9(9), 1998, pp. 973-976
65. DEPAS T; DEBRAUD F; ORLANDO L; NOLE F; MUNZONE E; ZAMPINO MG; FAZIO N; AAPRO MS; GOLDHIRSCH A
    HIGH-DOSE IFOSFAMIDE PLUS ADRIAMYCIN IN THE TREATMENT OF ADULT ADVANCED SOFT-TISSUE SARCOMAS - IS IT FEASIBLE
    Annals of oncology
    
    T. Depas et al., "HIGH-DOSE IFOSFAMIDE PLUS ADRIAMYCIN IN THE TREATMENT OF ADULT ADVANCED SOFT-TISSUE SARCOMAS - IS IT FEASIBLE", Annals of oncology, 9(8), 1998, pp. 917-919
66. BIFFI R; DEBRAUD E; ORSI E; POZZI S; MAURI S; GOLDHIRSCH A; NOLE F; ANDREONI B
    TOTALLY IMPLANTABLE CENTRAL VENOUS ACCESS PORTS FOR LONG-TERM CHEMOTHERAPY - A PROSPECTIVE-STUDY ANALYZING COMPLICATIONS AND COSTS OF 333 DEVICES WITH A MINIMUM FOLLOW-UP OF 180 DAYS
    Annals of oncology
    
    R. Biffi et al., "TOTALLY IMPLANTABLE CENTRAL VENOUS ACCESS PORTS FOR LONG-TERM CHEMOTHERAPY - A PROSPECTIVE-STUDY ANALYZING COMPLICATIONS AND COSTS OF 333 DEVICES WITH A MINIMUM FOLLOW-UP OF 180 DAYS", Annals of oncology, 9(7), 1998, pp. 767-773
67. GOLDHIRSCH A; COLLEONI M; COATES AS; CASTIGLIONEGERTSCH M; GELBER RD
    ADDING ADJUVANT CMF CHEMOTHERAPY TO EITHER RADIOTHERAPY OR TAMOXIFEN - ARE ALL CMFS ALIKE
    Annals of oncology
    
    A. Goldhirsch et al., "ADDING ADJUVANT CMF CHEMOTHERAPY TO EITHER RADIOTHERAPY OR TAMOXIFEN - ARE ALL CMFS ALIKE", Annals of oncology, 9(5), 1998, pp. 489-493
68. BORNER MM; CASTIGLIONE M; BACCHI M; WEBER W; HERRMANN R; FEY MF; PAGANI O; LEYVRAZ S; MORANT R; PESTALOZZI B; HANSELMANN S; GOLDHIRSCH A
    THE IMPACT OF ADDING LOW-DOSE LEUCOVORIN TO MONTHLY 5-FLUOROURACIL INADVANCED COLORECTAL-CARCINOMA - RESULTS OF A PHASE-III TRIAL
    Annals of oncology
    
    M.M. Borner et al., "THE IMPACT OF ADDING LOW-DOSE LEUCOVORIN TO MONTHLY 5-FLUOROURACIL INADVANCED COLORECTAL-CARCINOMA - RESULTS OF A PHASE-III TRIAL", Annals of oncology, 9(5), 1998, pp. 535-541
69. COLLEONI M; ORLANDO L; ROBERTSON C; NOLE F; PERUZZOTTI G; CASSANO R; ORVIETO E; VIALE G; GOLDHIRSCH A
    ASSESSMENT OF RESPONSE IN PRIMARY CHEMOTHERAPY FOR BREAST-CANCER
    Annals of oncology
    
    M. Colleoni et al., "ASSESSMENT OF RESPONSE IN PRIMARY CHEMOTHERAPY FOR BREAST-CANCER", Annals of oncology, 9(10), 1998, pp. 1140-1141
70. COLLEONI M; ORVIETO E; NOLE F; ORLANDO L; VIALE G; PERUZZOTTI G; SACCHINI V; VERONESI P; ORECCHIA R; GOLDHIRSCH A
    FACTORS PREDICTIVE OF RESPONSE TO PRIMARY CHEMOTHERAPY FOR OPERABLE BREAST-CANCER
    Annals of oncology
    
    M. Colleoni et al., "FACTORS PREDICTIVE OF RESPONSE TO PRIMARY CHEMOTHERAPY FOR OPERABLE BREAST-CANCER", Annals of oncology, 9, 1998, pp. 29-29
71. NOBERASCO C; PERUZZOTTI G; COLLEONI M; NOLE F; DEBRAUD F; MARTINELLI G; GOLDHIRSCH A
    HEPATIC TOXICITY DURING ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF) IN BREAST-CANCER
    Annals of oncology
    
    C. Noberasco et al., "HEPATIC TOXICITY DURING ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF) IN BREAST-CANCER", Annals of oncology, 9, 1998, pp. 30-30
72. NOLE F; COLLEONI M; DEBRAUD F; ZAMPINO MG; MINCHELLA I; ORLANDO L; VERONESI P; SACCHINI V; GOLDHIRSCH A
    PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER (OBC) USING A REGIMEN WITH A LOW SUBJECTIVE TOXIC BURDEN CONTAINING VINORELBINE (V), 5-FLUOROURACIL (FU) AND FOLINIC ACID (FA)
    Annals of oncology
    
    F. Nole et al., "PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER (OBC) USING A REGIMEN WITH A LOW SUBJECTIVE TOXIC BURDEN CONTAINING VINORELBINE (V), 5-FLUOROURACIL (FU) AND FOLINIC ACID (FA)", Annals of oncology, 9, 1998, pp. 39-39
73. PAGANI O; SESSA C; VANDENBULCKE T; MARTINELLI G; ZAMPINO G; NOLE F; ZIMATORE M; LOCATELLI M; CRIVELLARI D; BUONADONNA A; THURLIMANN B; HESS D; BORNER M; BAUER J; RIGGI M; RIVA A; GOLDHIRSCH A
    DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (D) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC)
    Annals of oncology
    
    O. Pagani et al., "DOSE-FINDING STUDY OF HIGH-DOSE EPIRUBICIN (E) AND DOCETAXEL (D) AS FIRST-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC)", Annals of oncology, 9, 1998, pp. 74-74
74. ROTH AD; MAIBACH R; MORANT R; PAGANI O; DEBRAUD F; BORNER MM; STUPP R; HERRMANN R; FAZIO N; SESSA C; GOLDHIRSCH A
    TAXOTERE-CISPLATIN-5FU (TCF) IN ADVANCED GASTRIC-CARCINOMA (AGC) - A PHASE I-II STUDY
    Annals of oncology
    
    A.D. Roth et al., "TAXOTERE-CISPLATIN-5FU (TCF) IN ADVANCED GASTRIC-CARCINOMA (AGC) - A PHASE I-II STUDY", Annals of oncology, 9, 1998, pp. 232-232
75. MUNZONE E; DEBRAUD F; BAGLIETTO L; ORLANDO L; GOLDHIRSCH A
    CA-19.9 SERUM MARKER AS A PREDICTOR OF RESPONSE TO CHEMOTHERAPY (CT) IN LOCALLY ADVANCED (LA) AND METASTATIC (M) PANCREATIC-CANCER (PC) PATIENTS
    Annals of oncology
    
    E. Munzone et al., "CA-19.9 SERUM MARKER AS A PREDICTOR OF RESPONSE TO CHEMOTHERAPY (CT) IN LOCALLY ADVANCED (LA) AND METASTATIC (M) PANCREATIC-CANCER (PC) PATIENTS", Annals of oncology, 9, 1998, pp. 247-247
76. FAZIO N; DEBRAUD F; COLLEONI M; ORSI F; GRASSO F; MARENGHI C; DEPAS T; GASPARETTO M; NOLE F; GOLDHIRSCH A
    HEPATIC INTRAARTERIAL CHEMOTHERAPY (HIAC) WITH FLUOROURACIL, CISPLATIN AND MITOMYCIN-C IN PRIMARY AND SECONDARY LIVER-TUMORS VIA PERCUTANEOUS CATHETER - A FEASIBILITY STUDY
    Annals of oncology
    
    N. Fazio et al., "HEPATIC INTRAARTERIAL CHEMOTHERAPY (HIAC) WITH FLUOROURACIL, CISPLATIN AND MITOMYCIN-C IN PRIMARY AND SECONDARY LIVER-TUMORS VIA PERCUTANEOUS CATHETER - A FEASIBILITY STUDY", Annals of oncology, 9, 1998, pp. 254-254
77. ZAMPINO MG; LOCATELLI M; DECOBELLI O; RUSSO R; SBANOTTO A; MARTINELLI G; DEBRAUD F; GOLDHIRSCH A
    HIGH-DOSE FOSFESTROL (F) CONTINUOUS-INFUSION (CI) IN OUTPATIENT SETTING OF HORMONE-REFRACTORY PROSTATIC-CANCER (HRPC)
    Annals of oncology
    
    M.G. Zampino et al., "HIGH-DOSE FOSFESTROL (F) CONTINUOUS-INFUSION (CI) IN OUTPATIENT SETTING OF HORMONE-REFRACTORY PROSTATIC-CANCER (HRPC)", Annals of oncology, 9, 1998, pp. 295-295
78. DEPAS T; DEBRAUD F; SESSA C; NOLE F; MINCHELLA I; CATANIA C; GOLDHIRSCH A
    PHASE-I STUDY USING WEEKLY TAXOL (T) AND GEMCITABINE (G) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)
    Annals of oncology
    
    T. Depas et al., "PHASE-I STUDY USING WEEKLY TAXOL (T) AND GEMCITABINE (G) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)", Annals of oncology, 9, 1998, pp. 375-375
79. GINSBURG AD; LEVINE MN; BOWMAN DM; OLIVOTTO IA; FIELDS LA; LITTLE CD; CANTIN J; MCGREGOR M; GOLDHIRSCH A; BRAMWELL V; GELMON K; BRYCE C; ALLAN S; NORRIS B; LATREILLE J; PATERSON ADH; TOMIAK E; TREMBLAY G; BAIRD R; BECKER P; BUTTS C; DANCEY JT; GOEL R; KVERN B; MILNE C; NAROD S; NOLAN E; THURLOW WH; WONG R
    ADJUVANT SYSTEMIC THERAPY FOR WOMEN WITH NODE-NEGATIVE BREAST-CANCER
    CMAJ. Canadian Medical Association journal
    
    A.D. Ginsburg et al., "ADJUVANT SYSTEMIC THERAPY FOR WOMEN WITH NODE-NEGATIVE BREAST-CANCER", CMAJ. Canadian Medical Association journal, 158, 1998, pp. 43-51
80. COLE BF; SOLALCELIGNY P; GELBER RD; LEPAGE E; GISSELBRECHT C; REYES F; SEBBAN C; SUGANO D; TENDLER C; GOLDHIRSCH A
    QUALITY-OF-LIFE-ADJUSTED SURVIVAL ANALYSIS OF INTERFERON-ALPHA-2B TREATMENT FOR ADVANCED FOLLICULAR LYMPHOMA - AN AID TO CLINICAL DECISION-MAKING
    Journal of clinical oncology
    
    B.F. Cole et al., "QUALITY-OF-LIFE-ADJUSTED SURVIVAL ANALYSIS OF INTERFERON-ALPHA-2B TREATMENT FOR ADVANCED FOLLICULAR LYMPHOMA - AN AID TO CLINICAL DECISION-MAKING", Journal of clinical oncology, 16(7), 1998, pp. 2339-2344
81. COLLEONI M; MARTINELLI G; BERETTA F; MARONE C; GALLINO A; FONTANA M; GRAFFEO R; ZAMPINO G; DEPAS T; CIPOLLA G; MARTINONI C; GOLDHIRSCH A
    INTRACAVITARY CHEMOTHERAPY WITH THIOTEPA IN MALIGNANT PERICARDIAL-EFFUSIONS - AN ACTIVE AND WELL-TOLERATED REGIMEN
    Journal of clinical oncology
    
    M. Colleoni et al., "INTRACAVITARY CHEMOTHERAPY WITH THIOTEPA IN MALIGNANT PERICARDIAL-EFFUSIONS - AN ACTIVE AND WELL-TOLERATED REGIMEN", Journal of clinical oncology, 16(7), 1998, pp. 2371-2376
82. GOLDHIRSCH A; COATES AS; COLLEONI M; CASTIGLIONEGERTSCH M; GELBER RD
    ADJUVANT CHEMOENDOCRINE THERAPY IN POSTMENOPAUSAL BREAST-CANCER - CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL DOSE AND SCHEDULE MAY MAKE A DIFFERENCE
    Journal of clinical oncology
    
    A. Goldhirsch et al., "ADJUVANT CHEMOENDOCRINE THERAPY IN POSTMENOPAUSAL BREAST-CANCER - CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL DOSE AND SCHEDULE MAY MAKE A DIFFERENCE", Journal of clinical oncology, 16(4), 1998, pp. 1358-1362
83. COLE BF; GELBER RD; GOLDHIRSCH A
    CAN THE Q-TWIST METHOD PROVIDE INFORMATION ON PATIENTS PREFERENCES WITHOUT COLLECTING PREFERENCE DATA FROM THE PATIENTS - IN REPLY
    Journal of clinical oncology
    
    B.F. Cole et al., "CAN THE Q-TWIST METHOD PROVIDE INFORMATION ON PATIENTS PREFERENCES WITHOUT COLLECTING PREFERENCE DATA FROM THE PATIENTS - IN REPLY", Journal of clinical oncology, 16(11), 1998, pp. 3718-3718
84. COLLEONI M; COATES A; PAGANI O; GOLDHIRSCH A
    COMBINED CHEMOENDOCRINE ADJUVANT THERAPY FOR PATIENTS WITH OPERABLE BREAST-CANCER - STILL A QUESTION
    Cancer treatment reviews
    
    M. Colleoni et al., "COMBINED CHEMOENDOCRINE ADJUVANT THERAPY FOR PATIENTS WITH OPERABLE BREAST-CANCER - STILL A QUESTION", Cancer treatment reviews, 24(1), 1998, pp. 15-26
85. COATES AS; GELBER RD; GOLDHIRSCH A
    SUBSETS WITHIN THE CHEMOTHERAPY OVERVIEW
    Lancet
    
    A.S. Coates et al., "SUBSETS WITHIN THE CHEMOTHERAPY OVERVIEW", Lancet, 352(9142), 1998, pp. 1783-1784
86. PARMAR MKB; TORRI V; BONAVENTURA A; BONAZZI C; COLOMBO N; DELALOYE JF; MARSONI S; MANGIONI C; SANDERCOCK J; SESSA C; WILLIAMS C; TINAZZI A; FLANN M; GEISER K; SCORPIGLIONE N; STEWART JF; CHAVES J; PALMEIRO E; CURTAIN A; MCCORMACK T; GENNATAS C; MARRAS F; OPPO TG; BALESTRINO M; MALZONI C; MALZONI M; BELLI M; GEMINIANI ML; CRESTANI G; MONACO A; VAVALA V; PIATTO E; BARATTINI G; FORNARA PG; CHETRI MC; SANTEUFEMIA G; ARTIOLI F; CARONE D; FANIZZA G; TRENTADUE R; PRIOLO D; SCOLLO P; NIGRO SC; PETRINA M; MASTRANTONIO P; SPANNA GD; ZAGNI R; BELLONI C; COLLEONI R; REDAELLI L; CAVAGNINI A; DICOSTANZO G; PERRONI D; ARIENTI S; ORFANOTTI G; CANTONI FM; SECLI R; BIANCHI A; MARTINELLO R; MOLLICA G; MAIZZI D; PICCHIARELLI ME; FIORINI G; BORSANI M; COLOMBO E; GARSIA S; MELGRATI L; PAGGI G; BRUNENGHI GM; CASINI M; ISA L; ALGERI R; PROZIO G; BELFIORE G; ANGELINI F; DAPRILE M; MORESCHI M; MAURI ML; NATALE N; SENZANI FM; PAVANATO G; POGGI G; GARUTI G; LUERTI M; CRUCIANI G; PAGANO F; BACCOLO M; PODDI ER; BOCCIOLONE L; SABELLI MA; MAGGI R; RESTELLI C; DANTONA A; LOCATELLI MC; PESSI A; RAINA A; CHIARI S; GABRIELE A; PITTELLI MR; IACOBELLI P; DOGLIOTTI L; GORZEGNO G; MUSSO P; VEGNA G; COCO G; ALLETTI DG; PICCIOTTO F; LUCCHESE V; EPIS A; DIPALUMBO VS; DRUDI G; RAVAIOLI A; ZAMPELLA D; MORANDI MG; GORGA G; ZUCCHELLI C; CARIELLO S; GALLETTO L; SUSSIO M; MASSACESI L; MASSACESI M; CARLI A; TUCCI E; TAJANI E; CORRADO G; BUMMA S; DURANDO A; MASSOBRIO M; SBERVEGLIERI M; BIASIO M; GUERCIO E; JURA R; DANESE S; WIERDIS T; FARNELLI C; TARANTINO G; GRASSI R; REPETTI F; ROCCHI B; GRAMPA M; ERCOLI A; GRISO C; SIGNORI E; ZANINI L; PRESTI M; KLIMEK M; URBANSKI K; BISWAS A; VIEGAS O; KOCHLI O; DREHER E; FEY M; BECK G; LUDIN J; BONNEFOI H; KRAUER F; BAUER J; DELMORE G; FURRER C; LORENZ U; THURLIMANN B; LORENZ U; BRONZ L; SANNA P; WYSS D; GOLDHIRSCH A; GYR T; LEIDI L; PASTORELLI G; PAGANI O; REY P; HAILER U; BENZ J; KAYE SB; REED NS; SYMONDS RP; ATKINSON RJ; AXFORD AT; RUSTIN G; SECKL MJ; GREEN JA; SCOTT IV; GUTHRIE D; HARPER PG; CALMAN F; DOBBS HJ; WEIR P; CASSONI A; LEDERMAN JA; SOUHAMI RL; BOZZINO J; ADAB F; REDMAN CWE; SCOBLE JE; PATERSON M; DANIEL F; COWLEY N; WILLIAMS CJ; SPOONER D; HONG A; MCILLMURRAY M; HENDYIBBS P; HALL V; IVESON TJ; WHITEHOUSE JMA; GARRY R; LAMONT A; ROBINSON A; TRASK CW; CLUBB AW; MURRELL D; NEWMAN G; WILKINS M; GOLDTHORP WO; ROBERTS JK; RADSTONE DJ; WHIPP MJ; LEDERMANN JA; PATER J; BUYSE M; OMURA G
    ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER
    Lancet
    
    M.K.B. Parmar et al., "ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER", Lancet, 352(9140), 1998, pp. 1571-1576
87. GOLDHIRSCH A
    CONSENSUS REACHED AT NEW EUROPEAN BREAST-CANCER MEETING (VOL 352, PG 1200, 1998)
    Lancet
    
    A. Goldhirsch, "CONSENSUS REACHED AT NEW EUROPEAN BREAST-CANCER MEETING (VOL 352, PG 1200, 1998)", Lancet, 352(9136), 1998, pp. 1316-1316
88. ABE O; ABE R; ENOMOTO K; KIKUCHI K; KOYAMA H; NOMURA Y; SAKAI K; SUGIMACHI K; TOMINAGA T; UCHINO J; YOSHIDA M; BENRAADT J; VANDEVELDE AO; VANDONGEN JA; VERMORKEN JB; GIOKAS G; LISSAIOS B; HARVEY VJ; HOLDAWAY TM; KAY RG; MASON BH; COATES A; FORBES JF; FOCAN C; LOBELLE JP; GATES GD; POWELL J; DURAND M; MAURIAC L; BARTHOLOMEUS S; PICCART MJ; GELMAN RS; HENDERSON IC; SHAPIRO CL; HANCOCK AK; MASOOD MB; PARKER D; PRICE JJ; JACKSON S; RAGAZ J; DELOZIER T; MACELESECH J; HAYBITTLE JL; BERRY D; BROADWATER G; CIRRINCIONE C; MUSS H; NORTON L; BAUM M; HOUGHTON J; RILEY D; DENT DM; GUDGEON CA; HACKING A; GORDON NH; DAVIS HL; ROMESTAING P; LEHINGUE Y; OWEN JR; MEIER P; HOWELL A; RIBEIRO GC; SWINDELL R; ALBANO J; DEOLIVEIRA CF; GERVASIO H; GORDILHO J; CARSTENSEN B; PALSHOF T; JOHANSEN H; KORZENIOWSKI S; SKOLYSZEWSKI J; PORTNOJ SM; ANDERSEN KW; AXELSSON CK; BLICHERTTOFT M; MOURIDSEN HT; OVERGAARD M; ROSE C; CORCORAN N; TRAMPISCH HJ; COMIS RL; DAVIDSON NE; GRAY R; ROBERT N; TORMEY DC; WOOD W; CHETTY U; FORREST P; JACK W; ROSSBACH J; SYLVESTER RJ; VANDEVELDE CJH; CUNNINGHAM MP; BONNETERRE J; FUMOLEAU P; NAMER M; BASTERT G; RAUSCHECKER H; SAUER R; SAUERBREI W; SCHAUER A; SCHUMACHER M; DESCHRYVER A; BELFIGLIO M; MARI E; NICOLUCCI A; SCORPIGLIONE N; YOSEF HMA; MCARDLE CS; SMITH DC; LARA PC; BOCCARDO F; RUBAGOTTI A; ERAZO A; MEDINA JY; IZUO M; MORISHITA Y; BENTLEY A; DORAN Z; FENTIMAN IS; HAYWARD JL; RUBENS RD; KAUFMANN M; JONAT W; SCHEURLEN H; VONFOURNIER D; FOUNTZILAS G; KLAFSTROM P; BLOMQVIST C; CUZICK J; MARGREITER R; CASTIGLIONE M; CAVILLI F; COLLINS J; FORBES J; GELBER RD; GOLDHIRSCH A; LINDTNER J; PRICE KN; RUDENSTAM CM; SENN HJ; BLISS JM; CHILVERS CED; COOMBES RC; MARTY M; BOROVIK R; BRUFMAN G; HAYAT H; ROBINSON E; WIGLER N; PANNUTI F; TAKASHIMA S; YASUTOMI T; SONOO H; YAMASHITA J; OGAWA M; WELVAART K; HUPPERETS PSGJ; BONTE J; TENGRUP I; TENNVALLNITTBY L; MARTIN P; ROMAIN S; INGLE JN; SUMAN VJ; BUZDAR AU; SMITH T; HAKES T; WITTES R; DELAHUERTA R; SAINZ MG; BONADONNA G; DELVECCHIO M; VALAGUSSA P; VERONESI U; DUBOIS JB; BIANCO AR; LIPPMAN ME; PIERCE LJ; SIMON R; STEINBERG SM; MYLES JD; PATER JL; PRITCHARD KI; ANDERSON S; BROWN A; BRYANT J; COSTANTINO J; DIGNAM J; FISHER B; REDMOND C; WIEAND S; WOLMARK N; JACKSON IM; PALMER MK; BENGTSSON NO; LARSSON LG; LYTHGOE JP; KISSIN M; HANNISDAL E; VARHAUG JE; NISSENMEYER R; BLAMEY RW; MITCHELL AK; ROBERTSON JFR; UEO H; MATHE G; MISSET JL; ABUZAHRA HT; CLARKE EA; MCLAUGHLIN JR; CLARK RM; LEVINE M; MORIMOTO K; SAWA K; TAKATSUKA Y; GUNDERSEN S; HAUERJENSEN M; HOST H; CROSSLEY E; HARRIS A; BEIGHTON A; CLARKE M; COLLINS R; DAVIES C; EVANS V; GODWIN J; GREAVES E; HARWOOD C; JACKSON D; JAMES S; LAU E; MEAD G; NAUGHTEN A; PETO R; TOOTH A; RAMBERT P; ASSELAIN B; SALMON RJ; VILCOQ JR; ARRIAGADA R; HILL C; LAPLANCHE A; LE MG; SPIELMANN M; COCCONI G; DIBLASIO B; CATALANO R; CREECH RH; BROCKSCHMIDT J; COOPER MR; ANDRYSEK O; BARKMANOVA J; FALKSON CI; ABRAHAM M; KLIJN JGM; TREURNIETDONKER AD; VANPUTTEN WLJ; EASTON D; POWLES TJ; GAZET JC; SEMIGLAZOV V; DESHPANDE N; DIMARTINO L; DOUGLAS P; LINDTNER A; NOTTER G; BRYANT AJS; EWING GH; KRUSHENKOSLOSKI JL; GEORGE WD; GOULD A; STEWART HJ; STRONER P; MOLLER TR; RYDEN S; CARSTENSEN J; HATSCHEK T; SODERBERG M; CARPENTER JT; ALBAIN K; CROWLEY J; GREEN S; MARTINO S; OSBORNE CK; RAVDIN PM; RUTQVIST LE; WALLGREN A; HOLM LE; THURLIMANN B; BRENNER H; HERCBERGS A; YOSHIMOTO M; DEBOER G; PATERSON AHG; MEAKIN JW; PANZARELLA T; NAJA A; BAHI J; REID M; SPITTLE M; SENANAYAKE F; BERGH J; HOLMBERG L; SEVELDA P; ZIELINSKY CC; GNANT M; JAKESZ R; BUCHANAN RB; CROSS M; DUNN JA; GILLESPIE WM; KELLY K; MORRISON JM; LITTON A; CHLEBOWSKI RT; BEZWODA WR; CAFFIER H
    POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
    Lancet
    
    O. Abe et al., "POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS", Lancet, 352(9132), 1998, pp. 930-942
89. Aapro, M; Goldhirsch, A
    New paradigms in the treatment of advanced breast cancer - Introduction
    SEMINARS IN ONCOLOGY
    
    M. Aapro e A. Goldhirsch, "New paradigms in the treatment of advanced breast cancer - Introduction", SEMIN ONCOL, 25(5), 1998, pp. 1-2
90. GOLDHIRSCH A; COATES AS; COLLEONI M; GELBER RD
    RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER
    The New England journal of medicine
    
    A. Goldhirsch et al., "RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER", The New England journal of medicine, 338(5), 1998, pp. 330-331
91. COLLEONI M; AUDISIO RA; DEBRAUD F; FAZIO N; MARTINELLI G; GOLDHIRSCH A
    PRACTICAL CONSIDERATIONS IN THE TREATMENT OF HEPATOCELLULAR-CARCINOMA
    Drugs
    
    M. Colleoni et al., "PRACTICAL CONSIDERATIONS IN THE TREATMENT OF HEPATOCELLULAR-CARCINOMA", Drugs, 55(3), 1998, pp. 367-382
92. PINDER SE; MURRAY S; ELLIS IO; TRIHIA H; ELSTON GW; GELBER RD; GOLDHIRSCH A; LINDTNER J; CORTESFUNES H; SIMONCINI E; BYRNE MJ; GOLOUH R; RUDENSTAM CM; CASTIGLIONEGERTSCH M; GUSTERSON BA
    THE IMPORTANCE OF THE HISTOLOGIC GRADE OF INVASIVE BREAST-CARCINOMA AND RESPONSE TO CHEMOTHERAPY
    Cancer
    
    S.E. Pinder et al., "THE IMPORTANCE OF THE HISTOLOGIC GRADE OF INVASIVE BREAST-CARCINOMA AND RESPONSE TO CHEMOTHERAPY", Cancer, 83(8), 1998, pp. 1529-1539
93. BERNHARD J; HURNY C; COATES AS; PETERSON HF; CASTIGLIONEGERTSCH M; GELBER RD; GALLIGIONI E; MARINI G; THURLIMANN B; FORBES JF; GOLDHIRSCH A; SENN HJ; RUDENSTAM CM
    FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS
    British Journal of Cancer
    
    J. Bernhard et al., "FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS", British Journal of Cancer, 78(5), 1998, pp. 686-693
94. GOLDHIRSCH A; GLICK JH; GELBER RD; SENN HJ
    MEETING HIGHLIGHTS - INTERNATIONAL CONSENSUS PANEL ON THE TREATMENT OF PRIMARY BREAST-CANCER
    Journal of the National Cancer Institute
    
    A. Goldhirsch et al., "MEETING HIGHLIGHTS - INTERNATIONAL CONSENSUS PANEL ON THE TREATMENT OF PRIMARY BREAST-CANCER", Journal of the National Cancer Institute, 90(21), 1998, pp. 1601-1608
95. LAFFER U; HARDER F; JAGGI P; METZGER U; AEBERHARD P; EGELI R; ARMA S; BARRAS JP; LAMPERT VD; MARTINOLI S; MULLER W; SCHRODER R; VONHUBEN R; WEBER W; CASTIGLIONE M; GOLDHIRSCH A; MAIBACH R; SCHMITZ SFH; GLOOR F; STAMM B; WALTZER U
    ASSOCIATION BETWEEN BLOOD-TRANSFUSION AND SURVIVAL IN A RANDOMIZED MULTICENTER TRIAL OF PERIOPERATIVE ADJUVANT PORTAL CHEMOTHERAPY IN PATIENTS WITH COLORECTAL-CANCER
    The European journal of surgery
    
    U. Laffer et al., "ASSOCIATION BETWEEN BLOOD-TRANSFUSION AND SURVIVAL IN A RANDOMIZED MULTICENTER TRIAL OF PERIOPERATIVE ADJUVANT PORTAL CHEMOTHERAPY IN PATIENTS WITH COLORECTAL-CANCER", The European journal of surgery, 163(9), 1997, pp. 693-701
96. COLLEONI M; GRAFFEO R; MARTINELLI G; GHIELMINI M; DEBRAUD P; ZAMPINO G; MARINI G; CAVALLI F; GOLDHIRSCH A
    CISPLATIN, ETOPOSIDE AND BLEOMYCIN INFUSION (PEBI REGIMEN) IN GOOD-RISK PATIENTS WITH GERM-CELL TUMORS
    Oncology Reports
    
    M. Colleoni et al., "CISPLATIN, ETOPOSIDE AND BLEOMYCIN INFUSION (PEBI REGIMEN) IN GOOD-RISK PATIENTS WITH GERM-CELL TUMORS", Oncology Reports, 4(5), 1997, pp. 913-916
97. GOLDHIRSCH A
    PREOPERATIVE AND POSTSURGICAL TREATMENT
    Breast
    
    A. Goldhirsch, "PREOPERATIVE AND POSTSURGICAL TREATMENT", Breast, 6(5), 1997, pp. 312-312
98. THURLIMANN B; CASTIGLIONE M; HSUSCHMITZ SF; CAVALLI F; BONNEFOI H; FEY MF; MORANT R; LOHNERT T; GOLDHIRSCH A
    FORMESTANE VERSUS MEGESTROL-ACETATE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS AFTER FAILURE OF TAMOXIFEN - A PHASE-III PROSPECTIVE RANDOMIZED CROSS-OVER TRIAL OF 2ND-LINE HORMONAL TREATMENT (SAKK-20 90)/
    European journal of cancer
    
    B. Thurlimann et al., "FORMESTANE VERSUS MEGESTROL-ACETATE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS AFTER FAILURE OF TAMOXIFEN - A PHASE-III PROSPECTIVE RANDOMIZED CROSS-OVER TRIAL OF 2ND-LINE HORMONAL TREATMENT (SAKK-20 90)/", European journal of cancer, 33(7), 1997, pp. 1017-1024
99. CASTIGLIONEGERTSCH M; TATTERSALL M; HACKING A; GOLDHIRSCH A; GUDGEON A; GELBER RD; LINDTNER J; COATES A; COLLINS J; ISLEY M; SENN HJ; RUDENSTAM CM
    RETREATING RECURRENT BREAST-CANCER WITH THE SAME CMF-CONTAINING REGIMEN USED AS ADJUVANT THERAPY
    European journal of cancer
    
    M. Castiglionegertsch et al., "RETREATING RECURRENT BREAST-CANCER WITH THE SAME CMF-CONTAINING REGIMEN USED AS ADJUVANT THERAPY", European journal of cancer, 33(14), 1997, pp. 2321-2325
100. COLLEONI M; GRAFFEO R; MARTINELLI G; GHIELMINI M; MARINI G; CAVALLI F; GOLDHIRSCH A
     CISPLATIN, ETOPOSIDE AND BLEOMYCIN INFUSION (PEBI REGIMEN) IN GOOD-RISK PATIENTS WITH GERM-CELL TUMORS
     European journal of cancer
     
     M. Colleoni et al., "CISPLATIN, ETOPOSIDE AND BLEOMYCIN INFUSION (PEBI REGIMEN) IN GOOD-RISK PATIENTS WITH GERM-CELL TUMORS", European journal of cancer, 33, 1997, pp. 176-176